VBL Therapeutics VB-201 drug reduces IBD severity
VBL Therapeutics, a clinical stage biotechnology company, has announced...
Alvine ALV003 drug meets primary endpoint in Phase 2a study
Alvine Pharmaceuticals' drug compound, ALV003, has met the primary...
Peregrine reports top-line data from bavituximab study
Peregrine Pharmaceuticals has announced positive results from its...
Ipsen, Active Biotech conclude half of planned recruitment in tasquinimod study
Active Biotech and Ipsen have announced that 600 patients have been...
Tokai announces positive galeterone data from Phase 1 study
Tokai Pharmaceuticals has reported additional data from a Phase 1 safety...
See all news
Meet Biovian at the Biotech Outsourcing Strategies Conference
Tuesday, May 08, 2012
by Biovian
Meet Biovian at the Biotech Outsourcing Strategies cmc2012 (BOS cmc) on...
Meet Biovian at Lyckad Läkemedelsutveckling in Stockholm
Tuesday, May 08, 2012
by Biovian
Meet Biovian at 'Lyckad Läkemedelsutveckling' seminar on 31 May 2012 at...
Fujifilm Diosynth Biotechnologies Invests in New Equipment and Labs at UK Facility
Tuesday, April 03, 2012
by Fujifilm Diosynth Biotechnologies
Fujifilm Diosynth Biotechnologies has completed the first phase of a...
Tissue Solutions Achieves Certification to ISO 9001
Friday, March 09, 2012
by Tissue Solutions
Tissue Solutions is pleased to announce that it has been awarded...
GlycoMar Releases New White Paper: Oligosaccharides in Drug Discovery
Monday, February 27, 2012
by GlycoMar
Glycobiology is concerned with the study of structure, biosynthesis,...
See all press releases